Physician in the Loop: Gastroenterology Transistor (https://transistor.fm) https://feeds.transistor.fm/physician-in-the-loop-gastroenterology The week's news in gastroenterology for gastroenterologists, every Monday in a few minutes: studies, new treatments and technology, AI tools, FDA actions and guidelines. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/gastroenterology/. Read by AI voices. Nomad Medical Group, PLLC 248ab3f4-4db7-540b-ac44-a3537bb9f4c3 yes en Tue, 06 Oct 2026 13:08:12 -0600 Tue, 06 Oct 2026 13:09:35 -0600 https://physicianintheloop.org/specialties/gastroenterology/ https://img.transistorcdn.com/huVwPe6GdA0GZ_qWeg98_IrsAWiL6YwsfNyz52TRd1w/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9hZGRk/YmU2NjliNzcxYmE5/OTY5NDIzMjQxNTZl/Zjk2ZC5qcGc.jpg Physician in the Loop: Gastroenterology https://physicianintheloop.org/specialties/gastroenterology/ episodic Nomad Medical The week's news in gastroenterology for gastroenterologists, every Monday in a few minutes: studies, new treatments and technology, AI tools, FDA actions and guidelines. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/gastroenterology/. Read by AI voices. The week's news in gastroenterology for gastroenterologists, every Monday in a few minutes: studies, new treatments and technology, AI tools, FDA actions and guidelines. gastroenterology, gastroenterology news, medicine, physicians, AI in medicine, weekly briefing Ryan Gillum No No Weekly Briefing for September 28 to October 4, 2026 1 1 Weekly Briefing for September 28 to October 4, 2026 full 09d49945-b2de-4c15-a5c3-32f3aeb36b62 https://share.transistor.fm/s/1d1037f1 The U.S. Multi-Society Task Force on Colorectal Cancer on Sept. 30 published 11 recommendations on serrated polyposis syndrome, which the announcement described as the most common gastrointestinal polyp syndrome.

Abbott began U.S. sales of SimpleScreen CRC, a blood test for colorectal cancer screening approved by the Food and Drug Administration (FDA). Mirum Pharmaceuticals said brelovitug met the primary end point of a phase 3 trial in chronic hepatitis delta.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/gastroenterology/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> The U.S. Multi-Society Task Force on Colorectal Cancer on Sept. 30 published 11 recommendations on serrated polyposis syndrome, which the announcement described as the most common gastrointestinal polyp syndrome.

Abbott began U.S. sales of SimpleScreen CRC, a blood test for colorectal cancer screening approved by the Food and Drug Administration (FDA). Mirum Pharmaceuticals said brelovitug met the primary end point of a phase 3 trial in chronic hepatitis delta.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/gastroenterology/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> Mon, 05 Oct 2026 21:32:11 -0600 Nomad Medical Nomad Medical 268 Task force issues serrated polyposis recommendations; Abbott launches SimpleScreen CRC blood test; brelovitug meets phase 3 goal in hepatitis delta Task force issues serrated polyposis recommendations; Abbott launches SimpleScreen CRC blood test; brelovitug meets phase 3 goal in hepatitis delta Gastroenterology,physicians,medical news,weekly briefing No